Cargando…

Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer

PURPOSE: Tumor angiogenesis controlled predominantly by vascular endothelial growth factor and its receptor (VEGF-VEGFR) interaction plays a key role in the growth and propagation of cancer cells. However, the newly formed network of blood vessels is disorganized and leaky. Pre-treatment with anti-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Kritika, Lim, Joline, Choo, Joan, Ow, Samuel Guan Wei, Wong, Andrea, Lee, Matilda, Chan, Ching Wan, Hartman, Mikael, Lim, Siew Eng, Ngoi, Natalie, Tang, Siau Wei, Ang, Yvonne, Chan, Gloria, Chong, Wan Qin, Tan, Hon Lyn, Tan, Sing Huang, Goh, Boon Cher, Lee, Soo Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841320/ https://www.ncbi.nlm.nih.gov/pubmed/34928481 http://dx.doi.org/10.1007/s10549-021-06470-7

Ejemplares similares

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors
por: Choo, Joan R. E., et al.
Publicado: (2022)

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
por: Ang, Yvonne L. E., et al.
Publicado: (2020)

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer
por: Wong, Andrea L.A., et al.
Publicado: (2016)

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia
por: Low, Jia Li, et al.
Publicado: (2022)

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
por: Lee, Matilda Xinwei, et al.
Publicado: (2022)

The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles()
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017)

Impact of contrast-enhanced mammography in surgical management of breast cancers for women with dense breasts: a dual-center, multi-disciplinary study in Asia
por: Goh, Yonggeng, et al.
Publicado: (2022)

Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma
por: Mizuno, Ryuichi, et al.
Publicado: (2017)

Anti-Angiogenic Treatment (Sunitinib) for Disseminated Malignant Haemangiopericytoma: A Case Study and Review of the Literature
por: Delgado, M., et al.
Publicado: (2011)

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
por: Tan, Wei Chang Colin, et al.
Publicado: (2020)

Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
por: Loh, Jerold, et al.
Publicado: (2023)

Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib
por: Beltran, Himisha, et al.
Publicado: (2014)

Bridging Sunitinib Exposure to Time‐to‐Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker
por: Ait‐Oudhia, S, et al.
Publicado: (2016)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer
por: Mirzaei, Hamid Reza, et al.
Publicado: (2014)

VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment
por: Patten, Steven G, et al.
Publicado: (2010)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
por: Mirzaei, Hamid Reza, et al.
Publicado: (2013)

Photoacoustic Tomography Appearance of Fat Necrosis: A First-in-Human Demonstration of Biochemical Signatures along with Histological Correlation
por: Goh, Yonggeng, et al.
Publicado: (2022)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy
por: Yeong, Joe, et al.
Publicado: (2022)

Biochemical and Pathological Response of Prostate Cancer in a Patient with Metastatic Renal Cell Carcinoma on Sunitinib Treatment
por: Song, Ik Chan, et al.
Publicado: (2009)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Sunitinib and other targeted therapies for renal cell carcinoma
por: Powles, T, et al.
Publicado: (2011)

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide
por: Borghini, Annalisa, et al.
Publicado: (2015)

Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
por: Lim, Joline S. J., et al.
Publicado: (2017)

Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips
por: Kim, So-Woon, et al.
Publicado: (2016)

Sustained systemic response paralleled with ovarian metastasis progression by sunitinib in metastatic renal cell carcinoma: Is this an anti-angiogenic potentiation of cancer?
por: Mete, Uttam K., et al.
Publicado: (2015)

The effects of community-based exercise modalities and volume on musculoskeletal health and functions in elderly people
por: Lim, Chin Leong, et al.
Publicado: (2023)

Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice
por: Lim, Adeline YL, et al.
Publicado: (2010)

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen
por: Bertheau, Philippe, et al.
Publicado: (2007)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021)

A propeptide toolbox for secretion optimization of Flavobacterium meningosepticum endopeptidase in Lactococcus lactis
por: Lim, Pei Yu, et al.
Publicado: (2017)

Intrahepatic splenosis: a world review
por: Toh, Weh Shien, et al.
Publicado: (2020)

Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis
por: Nguyen, Linh, et al.
Publicado: (2016)

Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis
por: Khoshroo, Sara, et al.
Publicado: (2021)

Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway
por: Wang, Tingting, et al.
Publicado: (2015)

Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers
por: Chan, Gloria H.J., et al.
Publicado: (2018)

Impact of microbial Aetiology on mortality in severe community-acquired pneumonia
por: Quah, Jessica, et al.
Publicado: (2018)

Deciphering the anti-angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer
por: Lv, Jin-Yan, et al.
Publicado: (2016)

Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma
por: Msaouel, Pavlos, et al.
Publicado: (2017)

Fusion of Multi-Modal Features to Enhance Dense Video Caption
por: Huang, Xuefei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_05l601p94jkgo9u99vsccail4f